Inventor · disambiguated record
Yufang Shi
Also filed as: SHI YUFANG
7 granted patents·8 pending applications·17 citations·filing 2009–2023
79Inventor score
Files withUNIV RUTGERS6SHANGHAI INST OF NUTRITION AND HEALTH CHINESE ACADEMY OF SCIENCES3SHANGHAI INST BIOLOGICAL SCIENCES CAS2SHANGHAI INST FOR BIOLOGICASCIENCES CHINESE ACADEMY OF SCIENCES1SHANGHAI KYGENT PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
15 records- 0185US9301979B2Method for attenuating immune response using mesenchymal stem cells and cytokinesUNIV RUTGERS·Filed 2014·Granted Apr 5, 2016·5 cites·6 claims
- 0282US8685728B2Kit containing stem cells and cytokines for use in attenuating immune responsesSHI YUFANG·Filed 2009·Granted Apr 1, 2014·9 cites·5 claims
- 0382US2024269188A1Methods for inducing an immune response by administering activated mesenchymal stem cellsUNIV RUTGERS·Filed 2023·Application pending·0 cites
- 0478US10046011B2Compositions for inducing or suppressing an immune responseUNIV RUTGERS·Filed 2013·Granted Aug 14, 2018·3 cites·2 claims
- 0573US12156889B2Methods of administering mesenchymal stem cells activated by cytokines for enhancing immunosuppressionUNIV RUTGERS·Filed 2021·Granted Dec 3, 2024·0 cites·8 claims
- 0672US11872250B2Methods for inducing an immune response by administering activated mesenchymal stem cellsUNIV RUTGERS·Filed 2021·Granted Jan 16, 2024·0 cites·3 claims
- 0764US10898523B2Methods of producing activated mesenchymal stem cellsUNIV RUTGERS·Filed 2018·Granted Jan 26, 2021·0 cites·2 claims
- 0864US2023364201A1Pharmaceutical composition containing insulin-like growth factor-2 and use thereofSHANGHAI INST OF NUTRITION AND HEALTH CHINESE ACADEMY OF SCIENCES·Filed 2023·Application pending·0 cites
- 0960US2024368134A1Aromatic compound, pharmaceutical composition, and application thereofSHANGHAI KYGENT PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1053US10071119B2Application of mesenchymal stem cells in prophylaxis or treatment of stress response-induced weakened immunitySHANGHAI INST BIOLOGICAL SCIENCES CAS·Filed 2014·Granted Sep 11, 2018·0 cites·9 claims
- 1153US2019381147A1Pharmaceutical composition containing insulin-like growth factor-2 and use thereofSHANGHAI INST FOR BIOLOGICASCIENCES CHINESE ACADEMY OF SCIENCES·Filed 2017·Application pending·0 cites
- 1250US2023165907A1Stem cell drug for treating diabetesUNIV SOOCHOW·Filed 2021·Application pending·0 cites
- 1346US2022401515A1Application of non-igf1r-binding substance in prevention and/or treatment of inflammatory diseasesSHANGHAI INST OF NUTRITION AND HEALTH CHINESE ACADEMY OF SCIENCES·Filed 2020·Application pending·0 cites
- 1443US2021038688A1Icam-1 marker and application thereofSHANGHAI INST OF NUTRITION AND HEALTH CHINESE ACADEMY OF SCIENCES·Filed 2019·Application pending·0 cites
- 1534US2018200301A1Low-Oxygen-Treated Mesenchymal Stem Cell and Use ThereofSHANGHAI INST BIOLOGICAL SCIENCES CAS·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →